To accelerate the time-to-market for life-saving biologics, pharmaceutical manufacturers must adopt a data-driven approach to container closure integrity testing (CCIT). By leveraging advanced non-destructive leak testing and high-precision barrier analysis, teams can qualify new systems faster, ensuring regulatory compliance and patient safety through every stage of the product lifecycle. Continue reading